Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Germany Pharmaceutical Packaging Market

ID: MRFR/PCM/44140-HCR
200 Pages
Varsha More
Last Updated: April 06, 2026
Germany Pharmaceutical Packaging Market Research Report By Product Outlook (Vials, Bottles and Jars, Cartridges and Syringes, Ampoules), By Material Type Outlook (Type I, Type II, Type III), and By Application Outlook (Generic Drugs, Branded Drugs, Biological Drugs)- Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Packaging & Transport, BY Formulation Type (USD Billion)
      1. 4.1.1 Solid
      2. 4.1.2 Liquid
      3. 4.1.3 Semi-Solid
      4. 4.1.4 Gaseous
    2. 4.2 Packaging & Transport, BY Material Type (USD Billion)
      1. 4.2.1 Plastic
      2. 4.2.2 Glass
      3. 4.2.3 Metal
      4. 4.2.4 Paper
    3. 4.3 Packaging & Transport, BY Packaging Type (USD Billion)
      1. 4.3.1 Bottles
      2. 4.3.2 Blisters
      3. 4.3.3 Syringes
      4. 4.3.4 Pouches
      5. 4.3.5 Boxes
    4. 4.4 Packaging & Transport, BY End Use (USD Billion)
      1. 4.4.1 Pharmaceutical Companies
      2. 4.4.2 Contract Packaging Organizations
      3. 4.4.3 Research Laboratories
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Packaging & Transport
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Packaging & Transport
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Amcor (AU)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 AptarGroup (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Becton Dickinson (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Gerresheimer (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 West Pharmaceutical Services (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Schott AG (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Catalent (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sanner (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 MediPharm (CA)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
    3. 6.3 GERMANY MARKET ANALYSIS BY MATERIAL TYPE
    4. 6.4 GERMANY MARKET ANALYSIS BY PACKAGING TYPE
    5. 6.5 GERMANY MARKET ANALYSIS BY END USE
    6. 6.6 KEY BUYING CRITERIA OF PACKAGING & TRANSPORT
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PACKAGING & TRANSPORT
    9. 6.9 DRIVERS IMPACT ANALYSIS: PACKAGING & TRANSPORT
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PACKAGING & TRANSPORT
    11. 6.11 SUPPLY / VALUE CHAIN: PACKAGING & TRANSPORT
    12. 6.12 PACKAGING & TRANSPORT, BY FORMULATION TYPE, 2024 (% SHARE)
    13. 6.13 PACKAGING & TRANSPORT, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 PACKAGING & TRANSPORT, BY MATERIAL TYPE, 2024 (% SHARE)
    15. 6.15 PACKAGING & TRANSPORT, BY MATERIAL TYPE, 2024 TO 2035 (USD Billion)
    16. 6.16 PACKAGING & TRANSPORT, BY PACKAGING TYPE, 2024 (% SHARE)
    17. 6.17 PACKAGING & TRANSPORT, BY PACKAGING TYPE, 2024 TO 2035 (USD Billion)
    18. 6.18 PACKAGING & TRANSPORT, BY END USE, 2024 (% SHARE)
    19. 6.19 PACKAGING & TRANSPORT, BY END USE, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY FORMULATION TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY PACKAGING TYPE, 2025-2035 (USD Billion)
      4. 7.2.4 BY END USE, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Germany Packaging & Transport Market Segmentation

Packaging & Transport By Formulation Type (USD Billion, 2025-2035)

  • Solid
  • Liquid
  • Semi-Solid
  • Gaseous

Packaging & Transport By Material Type (USD Billion, 2025-2035)

  • Plastic
  • Glass
  • Metal
  • Paper

Packaging & Transport By Packaging Type (USD Billion, 2025-2035)

  • Bottles
  • Blisters
  • Syringes
  • Pouches
  • Boxes

Packaging & Transport By End Use (USD Billion, 2025-2035)

  • Pharmaceutical Companies
  • Contract Packaging Organizations
  • Research Laboratories